Results 171 to 180 of about 14,435,352 (380)

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

open access: yesNature Reviews Neurology, 2018
Melanie D. Sweeney   +2 more
semanticscholar   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

open access: yesMolecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez   +5 more
wiley   +1 more source

Blood and Blood Products [PDF]

open access: yesJournal of Pharmacy and Pharmacology, 1950
openaire   +3 more sources

Detection and localization of surgically resectable cancers with a multi-analyte blood test

open access: yesScience, 2018
J. Cohen   +41 more
semanticscholar   +1 more source

Raphin‐1 mediates the survival and sensitivity to radiation of pediatric‐type diffuse high‐grade glioma via phosphorylated eukaryotic initiation factor 2α‐dependent and ‐independent processes

open access: yesMolecular Oncology, EarlyView.
Raphin‐1 reduces the survival of PED‐DHGG cells and enhances their radiation sensitivity through both PeIF2α‐dependent and PeIF2α‐independent mechanisms. Raphin‐1 sustains elevated levels of PeIF2α, contributing to its PeIF2α‐dependent effects. Additionally, raphin‐1 interacts with CReP to mediate a separate radiosensitizing pathway that operates ...
Karin Eytan   +4 more
wiley   +1 more source

Corrigendum: Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China

open access: yesFrontiers in Immunology, 2023
Jingyun Tang   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy